Exhibiting at VIV Asia 2025

Phibro Animal Health (Thailand) Limited is the Thai subsidiary of Phibro Animal Health Corporation (PAHC), a globally renowned company specializing in animal health, nutritional products, and vaccines. Operating under the umbrella of the multinational headquartered in Teaneck, New Jersey, USA, Phibro Thailand serves the country’s rapidly growing livestock and poultry sectors with science-driven health solutions and a strong emphasis on responsible animal care.

With a dedicated presence in Bangkok, the company plays a key role in delivering Phibro’s high-quality products, technical services, and innovation to Southeast Asian producers, integrators, and veterinary professionals.

Core Business

Phibro Animal Health (Thailand) Limited is focused on the marketing, distribution, and technical support of animal health and nutrition products. These include therapeutic antibiotics, antimicrobials, vaccines, and nutritional feed additives that help manage disease, improve productivity, and reduce environmental impact across livestock and poultry farming systems.

The Thai division works in close collaboration with regional and global Phibro R&D and manufacturing teams to ensure product compliance and efficacy under tropical farming conditions.

Product and Service Offerings

Phibro Thailand’s product portfolio includes:

• Antibiotics and Antimicrobials:

  • Terramycin® (Oxytetracycline): A broad-spectrum antibiotic used widely in poultry and swine for respiratory and intestinal infections.
  • Neo-Terramycin®: A combination of oxytetracycline and neomycin for synergistic antibacterial action.
  • Banminth® (Pyrantel Tartrate): Anthelmintic for pigs and poultry.
  • Mecadox® (Carbadox): Growth-promoting antimicrobial for swine used to reduce bacterial enteritis.

• Vaccines:

  • MJPRRS Vaccine: A proprietary vaccine targeting PRRSv (Porcine Reproductive and Respiratory Syndrome Virus), designed for improved immunity and reduced production losses.

• Nutritional and Functional Additives:

  • A range of products (via Phibro Nutrition) for improving feed efficiency, gut health, and mineral balance.

These products are supported with technical services including disease diagnostics, vaccination programs, and customized farm management protocols.

Specialization and Unique Selling Proposition

Phibro Thailand’s key differentiators stem from its integration of global research with local expertise:

• Backed by Global R&D: Access to Phibro’s worldwide innovation network with laboratories in the USA, Israel, and Brazil.
• Product Registration and Compliance: Licensed by Thailand’s Department of Livestock Development, with strong focus on product safety and efficacy.
• Veterinary-Led Support: On-ground technical team with deep understanding of local production challenges.
• Focus on Sustainable Animal Health: Products designed to reduce antibiotic resistance, support gut integrity, and boost vaccine efficiency.

These strengths make Phibro Thailand a trusted partner in disease prevention and production optimization.

Financial Performance

While country-specific financials are not disclosed separately, Phibro Animal Health Corporation (NASDAQ: PAHC) reported the following in its global 2023 annual report:

• Global Net Sales: USD 975 million
• Animal Health Segment Share: ~70% of total revenue
• APAC Region Growth: Double-digit year-on-year growth with Southeast Asia identified as a key emerging market
• Thailand Contribution: One of the top three Southeast Asian markets for Phibro

This growth is attributed to increased demand for PRRS vaccines, gut health solutions, and responsible antimicrobial use programs in swine and poultry.

Shipment Records

Trade intelligence and regional logistics reports indicate:

• Export-Import Base: Products imported into Thailand under Phibro’s GMP and FDA-approved licenses
• Product Distribution: Through local distributors and direct to major poultry and swine integrators
• Top-Selling Products in Thailand: Terramycin®, Banminth®, MJPRRS vaccine
• Estimated Annual Shipments: 200–300 consignments into Thailand with growing intra-ASEAN redistribution

All shipments are managed in compliance with Thai FDA and Ministry of Agriculture regulations.

Target Market

Phibro Thailand serves a broad professional client base:

• Integrated poultry and swine producers
• Commercial veterinary clinics and large farms
• Feed mills and nutrition consultancies
• Government veterinary services and research bodies

Its solutions are targeted at mid-to-large scale operations requiring performance-oriented, regulated products with reliable technical support.

Capabilities

• Technical Support: Regional veterinarians and nutritionists providing on-site audits, training, and diagnostic support
• Regulatory Affairs: Local team working closely with Thai FDA and DLD for registration and renewals
• Training & Education: Phibro Academy and technical workshops for clients and veterinary professionals
• Digital Support Tools: Online technical documentation, dosing calculators, and e-learning modules

The Thailand division acts as a bridge between Phibro’s global innovation and local farm-level implementation.

Certifications and Compliance

Phibro Thailand operates under stringent compliance regimes:

• DLD-approved veterinary drug distributor
• Products meet cGMP and FDA manufacturing standards
• Import licenses and product registrations with Thai Department of Livestock Development (DLD)
• Global pharmacovigilance program to monitor efficacy and safety

All products are tracked via batch control systems for full traceability.

Customer Testimonials

“Phibro’s MJPRRS vaccine helped us regain productivity after recurrent PRRS outbreaks. Their veterinary support and vaccination protocols are top-notch.”
— Somchai T., Swine Farm Manager, Thailand

“Terramycin remains one of our most reliable tools in respiratory disease management. It’s backed by years of field use and performance.”
— Dr. Narong S., Poultry Consultant, Central Thailand

Major Achievements

• Terramycin Leadership: One of the most recognized antibiotic brands in Thailand’s livestock sector
• PRRS Vaccine Success: MJPRRS vaccine adoption led to >30% reduction in mortality and production losses in field trials
• Technical Training Programs: Over 500 veterinary and production professionals trained via Phibro Academy in the past five years
• Sustainable Health Initiatives: Promoting antimicrobial stewardship through targeted usage and alternative strategies
• Market Expansion: Continued growth in ASEAN, with Thailand as a strategic hub for technical deployment and knowledge transfer

Phibro Animal Health (Thailand) Limited continues to empower animal producers with data-driven, sustainable, and scientifically validated health solutions—reinforcing its position as a preferred partner for livestock productivity and veterinary excellence in Southeast Asia.